Celularity CELU
NASDAQ CELU
$1.05 +0.03 (+2.94%)
At close: Oct 22, 2026 · 4:00 PM EDT

Celularity (CELU) Non Operating Interest Expenses (2025 - 2026)

Updated

Celularity (CELU) reported Non Operating Interest Expenses of $177,000 for Q2 2026, down 90.9% from $1.94 million a year earlier and down 49.7% from the prior quarter.

Analysis

Celularity (CELU) Non Operating Interest Expenses (2025 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Celularity's Non Operating Interest Expenses came in at $4.91 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn -
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn 217.00 Mn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn -
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn -
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn 462.00 Mn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn 435.00 Mn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn 673.00 Mn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn 247.00 Mn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn -
10 Celularity 30.75 Mn 23.50 Mn 3.09 Mn 177,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 177,000.00
Mar 31, 2026 352,000.00
Mar 31, 2025 2.44 Mn
API Access

Celularity Non Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=CELU&period=max&api_key=YOUR_API_KEY